Article
Author(s):
Toronto - A group of Canadian physicians who use Artecoll, an injectable currently awaiting FDA approval, is calling for the development of formal clinical guidelines and further research to help avoid adverse patient reactions.
“ARM Yourself with Knowledge": Emmy Graber, MD, MBA, Shares Insights on Acne, Rosacea, and More
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Elevating Physician Assistants: Acne Insights, Career Milestones, and Education at the 2024 SDPA Fall Conference
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
The Weekly Roundup: December 2-6
Dermoscopy Can Accurately Predict Treatment Success of Cryotherapy